Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies
J Zhang, Y Zhang, J Wang, Y Xia, J Zhang… - Signal transduction and …, 2024 - nature.com
Alzheimer's disease (AD) stands as the predominant form of dementia, presenting significant
and escalating global challenges. Its etiology is intricate and diverse, stemming from a …
and escalating global challenges. Its etiology is intricate and diverse, stemming from a …
Effects of COVID-19 on cognition and brain health
COVID-19 is associated with a range of neurological, cognitive, and mental health
symptoms both acutely and chronically that can persist for many months after infection in …
symptoms both acutely and chronically that can persist for many months after infection in …
[HTML][HTML] COVID-19 rebound after Paxlovid and Molnupiravir during January-June 2022
L Wang, NA Berger, PB Davis, DC Kaelber, ND Volkow… - MedRxiv, 2022 - ncbi.nlm.nih.gov
COVID-19 rebound after Paxlovid and Molnupiravir during January-June 2022 - PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and …
L Wang, QQ Wang, PB Davis, ND Volkow… - World …, 2022 - Wiley Online Library
Individuals with substance use disorders (SUDs) are at increased risk for COVID‐19
infection and for adverse outcomes of the infection. Though vaccines are highly effective …
infection and for adverse outcomes of the infection. Though vaccines are highly effective …
Association of COVID-19 with new-onset Alzheimer's disease
L Wang, PB Davis, ND Volkow… - Journal of …, 2022 - content.iospress.com
An infectious etiology of Alzheimer's disease has been postulated for decades. It remains
unknown whether SARS-CoV-2 viral infection is associated with increased risk for …
unknown whether SARS-CoV-2 viral infection is associated with increased risk for …
Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: a systematic review, meta-analysis and call for action
L Liu, SY Ni, W Yan, QD Lu, YM Zhao, YY Xu… - …, 2021 - thelancet.com
Abstract Background Coronavirus disease 2019 (COVID-19) has evolved into a worldwide
pandemic, and has been found to be closely associated with mental and neurological …
pandemic, and has been found to be closely associated with mental and neurological …
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
Background Dementia-like cognitive impairment is an increasingly reported complication of
SARS-CoV-2 infection. However, the underlying mechanisms responsible for this …
SARS-CoV-2 infection. However, the underlying mechanisms responsible for this …
COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: a clarion call for maintaining mitigation …
There has been limited data presented to characterize and quantify breakthrough SARS-
CoV-2 infections, hospitalizations, and mortality in vaccinated patients with hematologic …
CoV-2 infections, hospitalizations, and mortality in vaccinated patients with hematologic …
The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms
Abstract Coronavirus disease 2019 (COVID-19), which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is a life-threatening disease, especially …
respiratory syndrome coronavirus 2 (SARS-CoV-2), is a life-threatening disease, especially …
KG-Predict: A knowledge graph computational framework for drug repurposing
The emergence of large-scale phenotypic, genetic, and other multi-model biochemical data
has offered unprecedented opportunities for drug discovery including drug repurposing …
has offered unprecedented opportunities for drug discovery including drug repurposing …